The announcement of an impeachment inquiry by Speaker Nancy Pelosi (D-CA) took over the news last week and fed into rising tensions between both parties. Impeachment proceedings may have large implications for current Congressional efforts to pass drug pricing and surprise billing legislation. Many political analysts believe that the inquiry will stall any legislation from passing this year, but with both parties under pressure to achieve something, it is unclear how the remainder of the year will play out. [Included] is more about where top health care legislation stands today.

Also in Policy Brief:

• New Findings from California’s Surprise Billing Ban
• CMS’s Final Discharge Planning Rule Reduces Hospital Burden, Promotes Interoperability
• 340B Update
• A Look at the Federal Register
• In Other News